Montag A & Associates Inc Organon & Co. Transaction History

Montag A & Associates Inc

$1.97 Billion
Q2 2024

A detailed history of Montag A & Associates Inc transactions in Organon & Co. stock. As of the latest transaction made, Montag A & Associates Inc holds 1,089 shares of OGN stock, worth $20,505. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,089

Previous 1,089 -0.0%

Holding current value

$20,505

Previous $20,000 10.0%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	SELL	$13.78 - $18.8 $1,750 - $2,387	-127 Reduced 10.44%	1,089 $20,000
Q4 2023 Feb 07, 2024	SELL	$10.95 - $17.32 $985 - $1,558	-90 Reduced 6.89%	1,216 $17,000
Q3 2023 Nov 09, 2023	SELL	$16.59 - $23.77 $9,506 - $13,620	-573 Reduced 30.49%	1,306 $22,000
Q2 2023 Aug 09, 2023	BUY	$19.27 - $24.63 $1,560 - $1,995	81 Added 4.51%	1,879 $39,000
Q1 2023 May 11, 2023	SELL	$21.42 - $32.08 $73,170 - $109,585	-3,416 Reduced 65.52%	1,798 $42,000
Q4 2022 Feb 02, 2023	SELL	$23.31 - $28.61 $6,526 - $8,010	-280 Reduced 5.1%	5,214 $145,000
Q3 2022 Nov 09, 2022	SELL	$23.4 - $34.25 $4,656 - $6,815	-199 Reduced 3.5%	5,494 $129,000
Q2 2022 Aug 10, 2022	SELL	$31.66 - $38.9 $28,905 - $35,515	-913 Reduced 13.82%	5,693 $192,000
Q1 2022 May 02, 2022	SELL	$30.45 - $39.36 $59,438 - $76,830	-1,952 Reduced 22.81%	6,606 $231,000
Q4 2021 Feb 09, 2022	SELL	$28.67 - $37.13 $111,468 - $144,361	-3,888 Reduced 31.24%	8,558 $260,000
Q3 2021 Nov 08, 2021	SELL	$28.63 - $35.64 $118,900 - $148,012	-4,153 Reduced 25.02%	12,446 $408,000
Q2 2021 Aug 03, 2021	BUY	$28.45 - $38.0 $472,241 - $630,762	16,599 New	16,599 $502,000

Others Institutions Holding OGN

# of Institutions

795

Shares Held

191M

Call Options Held

1.59M

Put Options Held

931K

View Full List

About Organon & Co.

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $4.79B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

More about OGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Montag A & Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Montag A & Associates Inc with notifications on news.

Account

Montag A & Associates Inc Organon & Co. Transaction History